NASDAQ: NEO - NeoGenomics, Inc.

Yield per half year: +14.08%
Sector: Healthcare

NeoGenomics, Inc.

Underestimation
Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
P/E
3/10
46.4 48.77 -4.86% 367.38 -87.37%
P/S 4.4 33.76 -86.97%
P/BV 2.76 4.82 -42.68%
P/FCF -56.34 60.98 -192.4%
Ev/Ebitda -440.38 -22.12 1890.81%
Ev/S 4.85 22.56 -78.49%
Ev/FCF -93.5 68.75 -236%
E/P -0.0508 0.0178 -385.82%
Efficiency
Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Ebitda margin
0/10
-1.1 4.83 -122.81% 1.68 -165.58%
ROE -9.34 9.61 -197.26%
ROA -5.23 0.3359 -1657.69%
ROIC -2.29 7.63 -130%
ROS -14.87 -25.17 -40.92%
ROCE -8.4 15.33 -154.8%
Debt
Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Debt/Ebitda
10/10
-83.42 -3.67 2175.62% -30.53 173.2%
Nеt Debt/Ebitda -41.29 -3.44 1100.71%
Debt/Ratio 0.3235 0.1972 64.07%
Debt/Equity 5.31 1.65 222.24%
Debt/Net Income -6.18 10.31 -159.98%
Dividends
Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Dividend yield
0/10
0 0.5496 -100% 0 0%
Number of years of dividend growth 0 0.1053 -100%
DSI 0 0.2174 -100%
Average dividend growth 0 0.0654 -100%
Average percentage for 5 years 0 0.4928 -100%
Average percentage for payments 363.64 43.56 734.71%
Difference from average difference in sector -0.5496
Growth impulse
Parameter Grade Value Sector average Difference with sector, %
Growth impulse Revenue 5 years
6/10
44.73 -56.89 -178.63%
Growth impulse Ebitda 5 years -116.89 -64.81 80.36%
Growth impulse Net Income 5 years -1199.6 -58.33 1956.57%
Growth impulse FCF 5 years -1030.45 -47 2092.45%
Growth impulse EPS 5 years -1006.76 -32.41 3006.33%
IP Score
2.59/10

Similar companies

Illumina

Amarin

DENTSPLY SIRONA

ImmunoGen